Medication

U.S. authorities are accusing the two top officials of a Canadian company of operating a long-running scheme to…
Read More...

Prediction market event contracts on both clinical drug trials and Food and Drug Administration regulatory approvals…
Read More...

Measles outbreaks aren't just a public health threat. They can also be a financial burden on the U.S. — and the cost…
Read More...

The U.S. Food and Drug Administration is requiring new safety warnings on all GLP-1 drugs after finding evidence of a…
Read More...

"This medicine could be one of our largest medicines in history," Novartis CEO Vas Narasimhan told CNBC on Tuesday,…
Read More...

Moderna gave investors a scare as its stock plunged on Thursday. But it's still one of the hottest biotechs this…
Read More...

Leaked confidential data. A major stock sell-off. Beneath the chaos surrounding Moderna and Merck's latest data on…
Read More...

Moderna shares dropped as much as 25% on Thursday following the leak of partial data on its closely watched cancer…
Read More...

Novo on Tuesday said its next-generation obesity drug, CagriSema, showed 25% weight loss on average among adult women…
Read More...

AstraZeneca CEO Pascal Soriot told CNBC on Monday that Summit Therapeutics' lead drug could help power…
Read More...